CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
RealiseD focuses on improving clinical trials for rare and ultra-rare diseases by developing comprehensive methodologies and operational strategies. It aims to enhance drug development processes through collaboration among stakeholders, ensuring patient-centered approaches and regulatory compliance.
RealiseD implements a collaborative and compRehensive mEthodological and operational Approach to cLinical trIalS in rarE Diseasesenabling timely drug development and approval centred on patients’ needs with high level of evidence reachable in a limitedenvironment.
The core of RealiseD operational approaches includes the systematic procedures for patients’ referral, the certification ofclinical sites and filling the gaps for successful development of rare and ultra rare diseases[(U)RD]’ clinical…
SIGMUND FREUD PRIVATUNIVERSITAT WIEN GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Hasselt
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, BARCELONA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
